Taku Obara

Dr. Taku Obara


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2026 in Children
Verified
Journal Article
Open access
PDF file
GSGenki Shinoda
Genki Shinoda
MIMami Ishikuro
Mami Ishikuro
TMTaeka Matsubara
Taeka Matsubara
ANAoi Noda
Aoi Noda
KMKeiko Murakami
Keiko Murakami
TOTaku Obara
Taku Obara
Background/Objectives: Being overweight in childhood is a strong predictor of later obesity and related health disorders, underscoring the importance of the early identification of at-risk children. The aim of this study was to develop a prediction model for being overweight across childhood and adolescence using routine life-course health records available up to 18–23 months of age. Methods: We analyzed 1581 participants from the Tohoku Medical Megabank Birth and Three-Generation Cohort Study and constructed multivariable logistic regression models to predict being overweight at 36–47 months, 6 years, 11 years, and 14 years. Predictors included being overweight at 18–23 months, maternal characteristics, birth weight, and body mass index changes from birth to 18–23 months. Model performance was evaluated using the area under the curve (AUC), calibration, Brier scores, risk by score range, and stratified 10-fold cross-validation to assess the stability and robustness of predictive performance. Results: Being overweight at 18–23 months consistently showed strong associations with later overweight status. Model discrimination was moderate to high for early and middle childhood (AUC 0.873 at 36–47 months; 0.772 at 6 years) but modest for adolescence (AUC 0.720 and 0.692 at 11 and 14 years). Cross-validation demonstrated stable predictive performance across all age groups. Calibration and overall predictive accuracies were acceptable across all age groups. Conclusions: These results indicate that routine early life-course health records moderately predict the risk of being overweight, supporting their practical potential for early preventive interventions.

25 November 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
YTYuri Takahashi
Yuri Takahashi
ZWZen Watanabe
Zen Watanabe
NINoriyuki Iwama
Noriyuki Iwama
NKNatsumi Kumagai
Natsumi Kumagai
HHHirotaka Hamada
Hirotaka Hamada
TGThe Japan Environment and Children’s Study Group
The Japan Environment and Children’s Study Group
Background/Objectives: Perinatal mental disorders are important health issues that affect both mothers and their children. The Mediterranean diet (MD) is one of the most well-recognized healthy dietary patterns worldwide. Recent evidence suggests that MD may prevent or reduce the risk of perinatal mental disorders. This study investigated the association between MD adherence during pregnancy and psychological distress in a large cohort of Japanese births. Methods: Data were obtained from 80,271 pregnant women who participated in the Japan Environment and Children’s Study. Adherence to the MD was assessed using three scoring methods: the Mediterranean Diet Score (MDS), relative Mediterranean Diet (rMED), and Mediterranean Diet Score for Pregnancy (PMDS). Psychological distress was defined as a score of ≥13 on the Kessler 6-item Psychological Distress Scale (K6). Modified Poisson regression models were used to estimate risk ratios (RRs) and 95% confidence intervals (CIs). Population attributable fractions (PAFs) were calculated to quantify the proportion of psychological distress attributable to low MD adherence. Results: The adjusted RR for psychological distress in the low PMDS group was 1.17 (95% CI: 1.07, 1.28) compared with the high PMDS group. The adjusted PAF for low PMDS was 10.43% (95% CI: 4.81, 16.06). No statistically significant associations were detected between psychological distress and the MDS or rMED scores. Conclusions: This study suggests that high adherence to MD based on the PMDS during pregnancy may reduce the risk of psychological distress in Japanese women. Therefore, promoting MD during pregnancy could be a potential strategy for preventing perinatal mental disorders.

17 September 2026 in Archives of Women's Mental Health
Verified
Journal Article
Open access
PDF file
TITomofumi Ishikawa
Tomofumi Ishikawa
TSTakamasa Sakai
Takamasa Sakai
NINoriyuki Iwama
Noriyuki Iwama
RORyo Obara
Ryo Obara
KMKei Morishita
Kei Morishita
TOTaku Obara
Taku Obara

9 October 2026 in Neuroradiology
Verified
Journal Article
Open access
PDF file
SMShunji Mugikura
Shunji Mugikura
NMNaoko Mori
Naoko Mori
MSMegumi Satake
Megumi Satake
ICIppei Chiba
Ippei Chiba
MTMakiko Taira
Makiko Taira
MYMasayuki Yamamoto
Masayuki Yamamoto
Purpose The apolipoprotein E ε4 allele is a major genetic risk factor for Alzheimer’s disease, but its longitudinal effect on hippocampal atrophy is unclear. Selective hippocampal atrophy, defined as greater hippocampal volume (HpV) loss relative to total brain volume (TBV), is an early marker of preclinical Alzheimer’s disease. We examined age-related effects of APOE ε4 on longitudinal hippocampal atrophy in a large population-based cohort. Methods We analyzed MRI data from 9,453 adults in the Tohoku Medical Megabank MRI Study, including 5,774 participants with follow-up MRI after a mean interval of 4.7 years. Cross-sectional analyses used linear regression to assess HpV and TBV, adjusting for age, sex, APOE genotype, and intracranial volume. Longitudinal analyses assessed HpV-Ratio and TBV-Ratio, defined as the second MRI volume divided by the first volume, using regression models including age, sex, APOE genotype, MRI interval, and interaction terms between age and APOE genotype and between age and sex. Montreal Cognitive Assessment (MoCA) scores obtained at the second MRI were included to assess effects independent of cognition. Results No significant APOE genotype effects were observed in cross-sectional analyses. Longitudinally, ε4/ε4 carriers showed greater decline in HpV-Ratio than ε3/ε3 and ε3/ε4 carriers, and females showed lower HpV-Ratio than males. No APOE genotype or sex main effects were observed for TBV-Ratio. Interactions between age and APOE genotype and between age and sex demonstrated age-related acceleration of HpV-Ratio decline in ε4/ε4 carriers and females, and these effects persisted after adjustment for MoCA scores. Conclusion APOE ε4 homozygosity and female sex accelerate selective hippocampal atrophy in population-based cohorts.

23 May 2026 in Archives of Women's Mental Health
Verified
Journal Article
Open access
PDF file
TITomofumi Ishikawa
Tomofumi Ishikawa
TSTakamasa Sakai
Takamasa Sakai
NINoriyuki Iwama
Noriyuki Iwama
RORyo Obara
Ryo Obara
KMKei Morishita
Kei Morishita
TOTaku Obara
Taku Obara
Purpose: To evaluate the association between benzodiazepine exposure during early pregnancy and the risk of miscarriage, with a focus on dose–response, half-life, and individual agents. Methods: This nested case–control study was conducted using a large Japanese administrative database. Cases were defined as pregnancies ending in miscarriage between 2005 and 2023. Controls were randomly selected through risk-set sampling with replacement and matched in a 3:1 ratio. Conditional logistic regression, adjusted for confounders, was used to assess the associations. Results: Overall, 44,118 cases were matched with 132,317 controls, with a mean age of 33.2 years. The prevalence of benzodiazepine exposure was 1.7% and 1.2% among cases and controls, respectively. Etizolam (0.3%) had the highest prevalence, followed by alprazolam (0.3%) and brotizolam (0.2%) in both groups. Adjusted odds ratio (OR) for benzodiazepine exposure during early pregnancy was 1.241 (95% confidence interval: 1.136–1.357). Adjusted ORs for high-dose (1.212 [1.050–1.400]) and medium-dose (1.189 [1.037–1.363]) exposure were numerically higher than that for low-dose exposure (1.111 [0.934–1.322]). Adjusted OR for long-acting benzodiazepines (1.308 [1.124–1.522]) was numerically higher than those for intermediate- (1.132 [0.999–1.284]) and short-acting (1.157 [1.030–1.300]) agents. Adjusted ORs for etizolam, alprazolam, and brotizolam were 0.929 (0.782–1.103), 0.853 (0.707–1.030), and 1.454 (1.180–1.791), respectively. Conclusions: Benzodiazepine exposure during early pregnancy was modestly associated with an increased risk of miscarriage. Although associations tended to be stronger with higher dose levels and longer half-life categories, estimates across subgroups lacked precision and should be interpreted with caution.